comparemela.com
Latest Breaking News On - Cancer panels - Page 1 : comparemela.com
Genomic Cancer Panel and Profiling Market Set to Reach
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) The
Dublin
Ireland
United-states
America
Roche-ltd
Laboratory-corporation-of-america-holdings
Thermo-fisher-scientific-inc
Danaher-corporation-integrated
Genomic-cancer-panel
Illumina-inc
Invitae-corporation
Global Genomic Cancer Panel & Profiling Market Report
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) The
Dublin
Ireland
United-states
South-korea
America
Theragen-bio
Agilent-technologies-inc
Company-profiles
Common-hereditary-cancers-panel
Sciences-corp
Sciences-corporation
Genecast-biotechnology-co
Olaparib Did Not Improve PFS2, OS in SOLO3 Trial
Olaparib did not improve overall survival or the time from randomization to second progression or death, when compared with chemotherapy.
Boston
Massachusetts
United-states
Sutro-biopharma
Richard-penson
Wiley-blackwell
Roche-pharma
Wolters-kluwer-health
Array-biopharma-inc
Vascular-biogenics-ltd
Tesaro-inc
Eisai-inc
Outlook on the Genomic Cancer Panel and Profiling Global
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) The "Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with.
China
United-states
Dublin
Ireland
Miltenyi-biotec
Yourgene-elucigene
Agilent-dako
Qiagen-gmbh
Sysmex-inostics
Bristol-myers-squibb
Perkin-elmer
Siemens-healthineers
vimarsana © 2020. All Rights Reserved.